Amneal Pharmaceuticals, Inc. recalls

Amneal Pharmaceuticals, Inc. recalls Ranitidine Syrup Oral Solution 15 mg/mL 6. fl. oz. (473 mL), NDC 65162-664-90.

Amneal recalls Ranitidine Syrup Oral Solution 15 mg/mL 6 fl oz due to N-nitrosodimethylamine (NDMA) impurity found in the active pharmaceutical ingredient.

Amneal Pharmaceuticals, Inc. recalls Ranitidine Tablets, USP 150 mg, 1000-count bottles, NDC 53746-253-10.

Amneal Pharmaceuticals, Inc. recalls Ranitidine Tablets, USP 150 mg a).60-count bottles (NDC 65162-253-06) , b).100-count bottles (NDC 65162-253-10),

Amneal Pharmaceuticals, Inc. recalls Ranitidine Tablets, USP 300 mg, 250-count bottles, NDC 53746-254-02.

Amneal Pharmaceuticals, Inc. recalls Ranitidine Tablets, USP 300 mg - a).30-count bottles (NDC 65162-254-30), b).100-count bottles (NDC 65162-254-10) and

Amneal Pharmaceuticals, Inc. recalls Isotretinoin Capsules, USP 10 mg. Rx Only, 3 Prescription Blister Packs of 10- Capsules Each (30 Capsules)-.

Amneal Pharmaceuticals, Inc. recalls Benazepril HCl Tablets, USP 40 mg, 100 count bottles, Rx only, Distributed by Amneal Pharmaceuticals, Bridgewater, NJ

Amneal Pharmaceuticals, Inc. recalls Methylergonovine Maleate USP 0.2 mg Tablets a) 12 count (NDC 69238-1605-02) and b) 28 count bottles (NDC 69238-1605-08)

Amneal Pharmaceuticals, Inc. recalls Esterified Estrogens & Methyltestosterone Tablets, USP 0.625 mg/1.25 mg, 100-count bottles, Rx Only, Manufactured by: